These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 39107162)

  • 1. Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy.
    Jurj A; Fontana B; Varani G; Calin GA
    Trends Cancer; 2024 Sep; 10(9):809-824. PubMed ID: 39107162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
    Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
    ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of CXC chemokines and their receptors in cancer.
    Vinader V; Afarinkia K
    Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.
    Di Giorgio A; Tran TP; Duca M
    Future Med Chem; 2016 May; 8(7):803-16. PubMed ID: 27149207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.
    Petrek H; Yu AM
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00528. PubMed ID: 31859460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancer.
    Pavithra D; Sabitha K; Rajkumar T
    Comput Biol Chem; 2018 Dec; 77():442-454. PubMed ID: 30100328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNAs in cancer management.
    Kong YW; Ferland-McCollough D; Jackson TJ; Bushell M
    Lancet Oncol; 2012 Jun; 13(6):e249-58. PubMed ID: 22652233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Small Molecule Modulators of MicroRNA by Library Screening.
    Xiao Z; Chen Y
    Methods Mol Biol; 2017; 1517():169-178. PubMed ID: 27924482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulating miRNA by natural agents as a new strategy for cancer treatment.
    Sethi S; Li Y; Sarkar FH
    Curr Drug Targets; 2013 Sep; 14(10):1167-74. PubMed ID: 23834152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Legumain As a Novel Therapeutic Strategy in Cancers.
    Mai CW; Chung FF; Leong CO
    Curr Drug Targets; 2017; 18(11):1259-1268. PubMed ID: 27993111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of Small Molecule Inhibitors.
    Khera N; Rajput S
    J Cell Biochem; 2017 May; 118(5):959-961. PubMed ID: 27813176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications.
    Shekhar R; Kumari S; Vergish S; Tripathi P
    Int Rev Cell Mol Biol; 2024; 386():133-165. PubMed ID: 38782498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer.
    Lai X; Eberhardt M; Schmitz U; Vera J
    Nucleic Acids Res; 2019 Sep; 47(15):7753-7766. PubMed ID: 31340025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-155 as a novel clinical target for hematological malignancies.
    Witten L; Slack FJ
    Carcinogenesis; 2020 Mar; 41(1):2-7. PubMed ID: 31711135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy.
    Shi M; Cui J; Xie K
    Curr Drug Targets; 2013 Sep; 14(10):1192-202. PubMed ID: 23834153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.
    Velagapudi SP; Costales MG; Vummidi BR; Nakai Y; Angelbello AJ; Tran T; Haniff HS; Matsumoto Y; Wang ZF; Chatterjee AK; Childs-Disney JL; Disney MD
    Cell Chem Biol; 2018 Sep; 25(9):1086-1094.e7. PubMed ID: 30251629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
    O'Bryan S; Dong S; Mathis JM; Alahari SK
    Eur J Cancer; 2017 Feb; 72():1-11. PubMed ID: 27997852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance.
    Wu D; Huang C; Guan K
    Biochem Pharmacol; 2024 Aug; 226():116406. PubMed ID: 38969299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.
    Ellakwa DE; Mushtaq N; Khan S; Jabbar A; Abdelmalek MA; Wadan AS; Ellakwa TE; Raza A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5617-5630. PubMed ID: 38619588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.